tiprankstipranks
InspireMD (NSPR)
NASDAQ:NSPR

InspireMD (NSPR) Technical Analysis

673 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
InspireMD’s (NSPR) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting InspireMD is a Buy.
InspireMD’s (NSPR) 20-Day exponential moving average is 2.47, while InspireMD’s (NSPR) share price is $2.443, making it a Sell.
InspireMD’s (NSPR) 50-Day exponential moving average is 2.46, while InspireMD’s (NSPR) share price is $2.443, making it a Sell.

InspireMD (NSPR) Pivot Points

Jul 17, 2024, 04:36 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.31
2.36
2.41
2.46
2.51
2.56
2.61
Fibonacci
2.36
2.40
2.42
2.46
2.50
2.52
2.56
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

InspireMD (NSPR) Moving Averages

Jul 17, 2024, 04:36 PM
Period
Simple
Exponential
MA5
2.45Sell
2.45Sell
MA10
2.43Buy
2.45Sell
MA20
2.48Sell
2.47Sell
MA50
2.45Sell
2.46Sell
MA100
2.39Buy
2.48Sell
MA200
2.64Sell
2.70Sell
InspireMD’s (NSPR) 10-Day exponential moving average is 2.45, while InspireMD’s (NSPR) share price is $2.443, making it a Sell.
InspireMD’s (NSPR) 100-Day exponential moving average is 2.48, while InspireMD’s (NSPR) share price is $2.443, making it a Sell.
InspireMD’s (NSPR) stock price is $2.443 and InspireMD’s (NSPR) 50-day simple moving average is 2.45, creating a Sell signal.
InspireMD’s (NSPR) stock price is $2.443 and InspireMD’s (NSPR) 100-day simple moving average is 2.39, creating a Buy signal.
InspireMD’s (NSPR) stock price is $2.443 and InspireMD’s (NSPR) 200-day simple moving average is 2.64, creating a Sell signal.

InspireMD (NSPR) Technical Indicators

Jul 17, 2024, 04:36 PM
Name
Value
Implied Action
RSI (14)
47.26
Neutral
STOCH (9,6)
42.74
Neutral
STOCHRSI (14)
44.79
Neutral
MACD (12,26)
-0.02
Buy
ADX (14)
18.63
Buy
Williams %R
-59.38
Buy
CCI (14)
-46.18
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
46.81
Neutral
ROC
-3.94
Sell
InspireMD’s (NSPR) Relative Strength Index (RSI) is 47.26, creating a Neutral signal.
InspireMD’s (NSPR) Trend Strength Indicator (ADX) is 18.63, creating a Buy signal.
InspireMD’s (NSPR) Commodity Channel Index (CCI) is -46.18, creating a Neutral signal.
InspireMD’s (NSPR) Price Rate of Change (ROC) is -3.94, creating a Sell signal.

FAQ

Is NSPR a Buy, Hold, or Sell?
Based on NSPR’s technical indicators, NSPR is a Sell.
    What is NSPR’s RSI (14)?
    NSPR’s RSI (14) is 47.26, which suggests NSPR is a Neutral.
      What is NSPR’s MACD?
      NSPR’s MACD is -0.02, which suggests NSPR is a Buy.
        What is NSPR’s 5-day moving average?
        NSPR’s 5-day moving average is 2.45, which suggests NSPR is a Sell.
          What is NSPR’s 20-day moving average?
          NSPR 20-day moving average is 2.48, which suggests NSPR is a Sell.
            What is NSPR’s 50-day moving average?
            NSPR’s 50-day moving average is 2.45, which suggests NSPR is a Sell.
              What is NSPR’s 200-day moving average?
              NSPR’s 200-day moving average is 2.64, which suggests NSPR is a Sell.
                What is NSPR’s Williams % R (14)?
                NSPR’s Williams % R (14) is -59.38, which suggests NSPR is a Buy.
                  What is NSPR’s CCI (14)?
                  NSPR’s CCI (14) is -46.18, which suggests NSPR is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis